Siegfried Reich has ended his seven-year involvement with Effector Therapeutics. Reich co-founded Effector and served as its senior vice president of research but has moved on to take up the chief scientific officer position at Turning Point Therapeutics.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Что представляет собой сибутрамин - "жиросжигатель", который изымают из продажи | 0 | 6.31 | 13-08-2026 |